PositionTeijin Pharma Limited. and Laboratorios del Dr. Esteve S.A. acquired Oximeplus S.A. - Brief article

The European Commission granted clearance, on 8 January, to the acquisition of joint control of Oximeplus S.A. of Spain by Teijin Pharma Limited of Japan and Laboratorios del Dr. Esteve S.A. of Spain. Teijin Pharma supplies solutions for both pharmaceuticals and home health care. Esteve manufactures and...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT